With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. For more information, visit www.lantheus.com
You have chosen to your
information with
Lantheus
Team Members
Meridith Johnson
Lantheus
Vice President, Market Access
Bruce Carroll
Lantheus
Market Access Strategy Leader
Kate Holland
Lantheus
Vice President, Radiopharmaceutical Therapy, Strategy & Bus. Dev.
Yoshika Sherring
Lantheus
Director Patient Advocacy